Navigation Links
MMV and SCYNEXIS offer 400 active compounds for neglected disease drug research at no cost
Date:12/19/2011

In a bid to catalyse malaria and neglected disease drug discovery, MMV and SCYNEXIS, Inc. have assembled a Malaria Box of 400 carefully selected commercially available compounds with antimalarial activity and will provide it to researchers at no cost.

All 400 compounds in the Malaria Box have confirmed activity against the blood-stage of P. falciparum the most deadly of the malaria parasites and were selected by experienced medicinal chemists from an extensive screening of around four million compounds from the chemical libraries of St. Jude Children's Research Hospital, Novartis and GlaxoSmithKline. The Malaria Box includes 200 drug-like compounds as starting points for oral drug discovery as well as 200 probe-like compounds representing the broadest cross-section of chemical diversity for use as biological tools.

"The discovery of novel molecules to feed the pipeline of antimalarial drugs remains a constant challenge," said Tim Wells, CSO of Medicines for Malaria Venture, "and all the more pressing in light of emerging resistance to current therapies. One of the rate-limiting factors for drug discovery is access to the actual active compounds with which to conduct research. With the Malaria Box concept, together with our partner SCYNEXIS, we hope to overcome this hurdle by carefully selecting and making available the most promising molecules to propel malaria drug discovery to the next level."

The scope of the Malaria Box goes beyond the malaria field as the compounds could also be used in research for drugs for other parasitic or neglected diseases. Making the compounds available to the entire neglected-disease community could lead to a better understanding of the similarities and differences between these diseases.

"SCYNEXIS is pleased to participate with MMV in the Malaria Box project as part of our on-going commitment to address the tremendous challenges presented by neglected diseases," said Yves Ribeill, Pre
'/>"/>

Contact: Jaya Banerji
banerjij@mmv.org
41-079-707-7181
Medicines for Malaria Venture
Source:Eurekalert

Page: 1 2

Related biology news :

1. BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS
2. Ancient dry spells offer clues about the future of drought
3. Cheap beads offer alternative solar-heating storage
4. 2 top biological imaging centers offer powerful free online tool to researchers and public
5. Submarine springs offer preview of ocean acidification effects on coral reefs
6. BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS
7. Targeted antibacterial proteins may offer antibiotic alternative
8. Novel monoclonal antibody offers potential treatment for tumors resistant to VEGF therapy
9. Ultrathin flexible brain implant offers unique look at seizures in NIH-funded research
10. New report offers broad approach to assessing impacts of ecological damage
11. Evolution offers clues to leading cause of death during childbirth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015  Analyst Report Issued by Small Cap IR. In 2011, ... planet-wide, transactions at merchants on the leading payment cards rose ... credit, debit, and prepaid cards reached 6.54 billion.  Eight million ... card usage in 2012, and credit and debit card fraud ...
(Date:1/22/2015)... Inc. , a market leader of iris-based identity authentication solutions, ... the new role of Senior Vice President of Mobile and ... platforms and wearable solutions for EyeLock,s technologies. Gerber brings more ... industry to his role at EyeLock, with expertise in human ...
(Date:12/22/2014)... Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce market, ... Apollo Robbins for the 2015 International CES debut ... Apollo Robbins will be at the NXT-ID booth January ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
... light-emitting molecules have enabled researchers to visualize a ... surface using only infrared light. A team of ... University of Pennsylvania and the University of Minnesota ... surface of a polymersome, a cell-like vesicle, to ...
... drastically reduced the incidence of Kaposi's sarcoma in ... many developing countries. Now, researchers have discovered one ... traditionally associated with AIDS ?triggers severe inflammation. , ... investigator, and HHMI associate Craig McCormick, who are ...
... devices intended to optimize the cardiac function of patients ... patients might be at higher risk of dying suddenly ... Medical Center. , Besides maintaining optimal electrical stimulation to ... devices are giving cardiologists a new view of subtle ...
Cached Biology News:Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin 2How an AIDS-Related Cancer Unleashes Inflammation 2How an AIDS-Related Cancer Unleashes Inflammation 3Implanted Devices Detect High-Risk Heart Failure Patients 2Implanted Devices Detect High-Risk Heart Failure Patients 3
(Date:1/23/2015)... , Jan. 23, 2015  Array BioPharma Inc. (NASDAQ: ... reached a definitive agreement with Novartis Pharma AG to ... currently in Phase 3 development.  This agreement is conditional on ... PLC (GSK) on April 22, 2014, which are expected to ...
(Date:1/22/2015)... Bedford, NH (PRWEB) January 22, 2015 ... offers a table top laboratory homogenizer, the PandaPLUS 2000, ... nanoparticles, nanodispersions, nanoemulsions , and cell disruption . ... processing dairy products, fruit juices, liquid food, food additives ...
(Date:1/22/2015)... 22, 2015 Crystal Diagnostics (CDx) Xpress System, ... has received AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing ... collectively referred to as STEC or the “Big-6”) as well ... unit (cfu) per 325 g of raw ground beef and ...
(Date:1/22/2015)... Switzerland (PRWEB) January 22, 2015 Selexis ... characterized mammalian Research Cell Banks (RCBs) used for drug ... Research Cell Banks will include Next-Generation Sequencing ... genetic architecture de-risks biologic manufacturing by ensuring the integrity ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2
... National Ergonomics Conference and Exposition (NECE) at Caesars Palace, Las ... annual gathering of ergonomics decision makers and ergonomics product sellers ... all of the 50 states, Canada, and a dozen foreign ... , Attendees from Apple, Bayer, Chevron, ...
... the American Society of Hematology Annual Meeting , ... Corporation (Nasdaq: ACEL ) today announced that American ... (2008 112: Abstract 4205 & 2008 112: Abstract 4010) ... in chronic lymphocytic leukemia (CLL) and acute myeloblastic leukemia (AML) ...
... Growth Of 23% , , ... Microbix announced results for the fiscal year ended September 30, ... fund Microbix Biosystems Inc.,s (TSX:MBX) late-stage pipeline opportunities which are ... term, according to William J. Gastle, CEO of the Company. ...
Cached Biology Technology:National Ergonomics Expo Sees 86% On-Site Exhibitor Renewal Rate for 2009; New Products from Contour Design, Equipois, Goldtouch and Herman Miller Win 2008 NECE Attendees' Choice New Product Awards 2Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 2Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 3Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 4Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 5Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 2Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 3Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 4
... Pathway Studio Enterprise is integrated informatics ... regulatory mechanisms and drug response modeling. ... the worlds largest knowledge base of ... with MedScan module capable of extracting ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... Preparation Note: Prepared by a ... C.W., et al., Biotechnol. Bioeng., ... Definition: One unit will yield an ... 1.0 ml of water (1 cm ...
... White solid. PACKAGED UNDER INERT GAS. DO ... resin with applications similar to those of DTT ... , and 233155 ) but with the ... to the system. REDUCTACRYL™ Reagent can be used ...
Biology Products: